The findings revealed that the concurrent editing of the E6 and E7 genes, along with their respective promoters, via the CRISPR/Cas9 system, precipitated the accumulation of p53 and p21 proteins, significantly inhibiting the propagation of cervical carcinoma cell cultures under laboratory conditions. This evidence concerns the gene TP53 and cervical carcinoma.